CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands
- PMID: 30233657
- PMCID: PMC6134731
CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands
Abstract
Background: CD44 is a transmembranous proteoglycan, with a main role of cell adhesion to other cells and to extracellular matrix involved in the preservation of three-dimensional structure of organs. Pleomorphic adenoma (PA) is a common benign salivary gland tumor, composed of myoepithelial and ductal components. Carcinoma ex-PA (CXPA) is malignant transformation of the epithelial elements in PA. The aim of this study was to evaluate CD44 expression by immunohistochemistry in these two tumors and normal salivary gland near these tumors.
Materials and methods: In this cross-sectional immunohistochemical study, 40 paraffin blocks (formalin fixed, paraffin embedded) with thirty belonging to PA and ten blocks of CXPA and 18 paraffinized blocks of normal salivary glands' tissue adjacent to tumoral tissue (13 in the vicinity of PA and 5 in the vicinity of CXPA) were selected. Immunohistochemical expression of CD44 was observed and compared with each other. For data analysis, we used Chi-square, Kruskal-Wallis, and Mann-Whitney tests and the quantity of P values was considered 0.05.
Results: There was a significant difference in CD44 expression frequency between PA, CXPA, and normal salivary glands with higher expression noted in CXPA. Furthermore, expression frequency of CD44 in adjacent normal salivary gland of CXPA was significantly higher than PA. There was no significant difference in the expression of CD44 with respect to lymph node metastasis.
Conclusion: Higher expression of CD44 in CXPA might illustrate CD44's role in malignant transformation of PA.
Keywords: CD44; pleomorphic adenoma; salivary glands.
Conflict of interest statement
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or nonfinancial in this article.
Figures
Similar articles
-
Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.Front Oral Health. 2023 Apr 17;4:942604. doi: 10.3389/froh.2023.942604. eCollection 2023. Front Oral Health. 2023. PMID: 37138857 Free PMC article. Review.
-
[Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].Otolaryngol Pol. 2007;61(5):687-93. doi: 10.1016/S0030-6657(07)70507-3. Otolaryngol Pol. 2007. PMID: 18552001 Polish.
-
An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.J Oral Pathol Med. 2008 Nov;37(10):634-8. doi: 10.1111/j.1600-0714.2008.00680.x. Epub 2008 Jul 29. J Oral Pathol Med. 2008. PMID: 18673415
-
Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.Braz Dent J. 2015 Jul-Aug;26(4):416-21. doi: 10.1590/0103-6440201300369. Braz Dent J. 2015. PMID: 26312983
-
Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.Head Neck Pathol. 2018 Mar;12(1):82-88. doi: 10.1007/s12105-017-0829-7. Epub 2017 Jun 6. Head Neck Pathol. 2018. PMID: 28589437 Free PMC article. Review.
Cited by
-
Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.Front Oral Health. 2023 Apr 17;4:942604. doi: 10.3389/froh.2023.942604. eCollection 2023. Front Oral Health. 2023. PMID: 37138857 Free PMC article. Review.
-
CD44 and EPCAM expression in pleomorphic adenoma and mucoepidermoid carcinoma: An immunohistochemical method.Dent Res J (Isfahan). 2025 Apr 24;22:16. doi: 10.4103/drj.drj_545_24. eCollection 2025. Dent Res J (Isfahan). 2025. PMID: 40351859 Free PMC article.
-
Evaluation of VEGF expression correlates with COX-2 expression in pleomorphic adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma.Dent Res J (Isfahan). 2020 Mar 17;17(2):100-106. eCollection 2020 Mar-Apr. Dent Res J (Isfahan). 2020. PMID: 32435431 Free PMC article.
References
-
- Neville BW, Damm DD, Chi AC, Allen CM. Oral and Maxillofacial Pathology. Canada Elsevier Health Sciences. 2016:444, 460.
-
- Stennert E, Guntinas-Lichius O, Klussmann JP, Arnold G. Histopathology of pleomorphic adenoma in the parotid gland: A prospective unselected series of 100 cases. Laryngoscope. 2001;111:2195–200. - PubMed
-
- Ohtaké S, Cheng J, Ida H, Suzuki M, Ohshiro K, Zhang W, et al. Precancerous foci in pleomorphic adenoma of the salivary gland: Recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med. 2002;31:590–7. - PubMed
-
- Marioni G, Marino F, Stramare R, Marchese-Ragona R, Staffieri A. Benign metastasizing pleomorphic adenoma of the parotid gland: A clinicopathologic puzzle. Head Neck. 2003;25:1071–6. - PubMed
-
- Eneroth CM. Histological and clinical aspects of parotid tumours. Acta Otolaryngol Suppl. 1964;188(Suppl 191):1–99. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous